理解美国肾移植后1年肾功能的变化趋势
该研究纳入2001至2013年间接受肾移植的189,944例患者,分析移植后1年平均eGFR的时间趋势及其与临床实践变化的关系。结果显示,尽管受者和供者特征趋于不利,但1年平均eGFR基本保持稳定;免疫抑制实践的改善对eGFR有正面效应,抵消了受者/供者特征的不利影响。
要点
- 2001-2005至2011-2013年间, deceased 和 living 供肾移植受者的1年平均eGFR差异分别为1.34和0.66 ml/min per 1.73 m2,基本不变。
- 受者平均年龄增加且边缘供器官使用增多,校正这些趋势后显示出更大的eGFR时间改善。
- 免疫抑制实践的变化对移植后平均eGFR有正面效应,平衡了受者/供者特征的不利影响。
核心结论
- 尽管受者和供者特征日益不利,移植后1年平均eGFR保持稳定;随着ESRD人群老龄化和器官持续短缺,维持平均eGFR需要持续改善免疫抑制和移植后其他方面的护理。
研究设计与样本
- 队列研究,纳入2001至2013年间接受肾移植的189,944例患者,使用线性回归模型分析实践变化对全国移植后eGFR趋势的影响。
主要发现
- 2001-2005至2011-2013年间, deceased 供肾移植受者1年平均eGFR差异为1.34(95%CI 1.03至1.65)ml/min per 1.73 m2, living 供肾移植受者差异为0.66(95%CI 0.32至1.01)ml/min per 1.73 m2,基本不变。
- 受者平均年龄增加且更多边缘器官被使用,校正这些趋势后显示出更大的移植后eGFR时间改善。
- 免疫抑制实践的变化对移植后平均eGFR有正面效应,并平衡了受者/供者特征的负面效应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lower eGFR 1 year after kidney transplant is associated with shorter allograft and patient survival. We examined how practice changes in the past decade correlated with time trends in average eGFR at 1 year after kidney transplant in the United States in a cohort of 189,944 patients who received a kidney transplant between 2001 and 2013. We calculated the average eGFR at 1 year after transplant for the recipient cohort of each year using the appropriate Modification of Diet in Renal Disease equation depending on the prevailing methodology of creatinine measurement, and used linear regression to model the effects of practice changes on the national post-transplant eGFR trend. Between the 2001-2005 period and the 2011-2013 period, average 1-year post-transplant eGFR remained essentially unchanged, with differences of 1.34 (95% confidence interval, 1.03 to 1.65) ml/min per 1.73 m2 and 0.66 (95% confidence interval, 0.32 to 1.01) ml/min per 1.73 m2 among deceased and living donor kidney transplant recipients, respectively. Over time, the mean age of recipients increased and more marginal organs were used; adjusting for these trends unmasked a larger temporal improvement in post-transplant eGFR. However, changes in immunosuppression practice had a positive effect on average post-transplant eGFR and balanced out the negative effect of recipient/donor characteristics. In conclusion, average 1-year post-transplant eGFR remained stable, despite increasingly unfavorable attributes in recipients and donors. With an aging ESRD population and continued organ shortage, preservation of average post-transplant eGFR will require sustained improvement in immunosuppression and other aspects of post-transplant care.
引用
- Huang Y, Tilea A, Gillespie B, et al. Understanding Trends in Kidney Function 1 Year after Kidney Transplant in the United States. J Am Soc Nephrol. 2017. PMID: 28270413. doi:10.1681/ASN.2016050543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。